|
π
|
EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis
22 auth.
M. Yates,
R. Watts,
I. Bajema,
M. Cid,
B. Crestani,
T. Hauser,
B. Hellmich,
J. Holle,
M. Laudien,
M. Little,
...
R. Luqmani,
A. Mahr,
P. Merkel,
J. Mills,
J. Mooney,
M. Segelmark,
V. Tesar,
K. Westman,
A. Vaglio,
N. YalΓ§Δ±ndaΔ,
D. Jayne,
C. Mukhtyar
|
10 |
2016 |
10
π
|
|
π
|
BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis.
13 auth.
E. Ntatsaki,
D. Carruthers,
K. Chakravarty,
D. D'cruz,
L. Harper,
D. Jayne,
R. Luqmani,
J. Mills,
J. Mooney,
M. Venning,
...
R. Watts,
Bsr,
Guidelines Bhpr Standards
|
8 |
2007 |
8
π
|
|
π
|
BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis.
11 auth.
E. Ntatsaki,
D. Carruthers,
K. Chakravarty,
D. D'cruz,
L. Harper,
D. Jayne,
...
R. Luqmani,
J. Mills,
J. Mooney,
M. Venning,
R. Watts
|
7 |
2014 |
7
π
|
|
π¬
|
The epidemiology of Takayasu arteritis in the UK.
R. Watts,
A. Al-Taiar,
J. Mooney,
D. Scott,
A. Macgregor
|
7 |
2009 |
7
π¬
|
|
π
|
BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists.
10 auth.
K. Chakravarty,
H. Mcdonald,
T. Pullar,
A. Taggart,
R. Chalmers,
S. Oliver,
...
J. Mooney,
M. Somerville,
A. Bosworth,
T. Kennedy
|
7 |
2008 |
7
π
|
|
π¬
|
The contrasting epidemiology of granulomatosis with polyangiitis (Wegener's) and microscopic polyangiitis.
R. Watts,
J. Mooney,
J. Skinner,
D. Scott,
A. Macgregor
|
7 |
2012 |
7
π¬
|
|
π¬
|
Rheumatoid vasculitis: becoming extinct?
R. Watts,
J. Mooney,
S. Lane,
D. Scott
|
6 |
2004 |
6
π¬
|
|
π
|
BSR and BHPR guideline for the prescription and monitoring of non-biologic disease-modifying anti-rheumatic drugs.
15 auth.
J. Ledingham,
N. Gullick,
K. Irving,
R. Gorodkin,
M. Aris,
J. Burke,
P. Gordon,
D. Christidis,
Sarah Galloway,
E. Hayes,
...
Andrew P. D. Jeffries,
S. Mercer,
J. Mooney,
Sander I van Leuven,
J. Galloway
|
6 |
2017 |
6
π
|
|
π¬
|
Systemic rheumatoid vasculitis in the era of modern immunosuppressive therapy.
E. Ntatsaki,
J. Mooney,
D. Scott,
R. Watts
|
6 |
2014 |
6
π¬
|
|
π
|
BSR and BHPR guideline for the prescription and monitoring of non-biologic disease-modifying anti-rheumatic drugs.
15 auth.
J. Ledingham,
N. Gullick,
K. Irving,
R. Gorodkin,
M. Aris,
J. Burke,
P. Gordon,
D. Christidis,
Sarah Galloway,
E. Hayes,
...
Andrew P. D. Jeffries,
S. Mercer,
J. Mooney,
Sander I van Leuven,
J. Galloway
|
6 |
2017 |
6
π
|
|
π¦
|
Unusual features of serous neoplasms of low malignant potential during pregnancy.
J. Mooney,
Elvio G. Silva,
C. Tornos,
D. Gershenson
|
5 |
1997 |
5
π¦
|
